Selecta Biosciences Inc.

1.56+0.0200+1.30%Vol 582 3001Y Perf -72.38%
Dec 5th, 2019 11:35
BID1.56 ASK1.57
Open1.56 Previous Close1.54
Pre-Market1.54 After-Market-
 - -%  - -%
Target Price
6.67 
Analyst Rating
Strong Buy 1.00
Potential %
327.56 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/100/100 
Growth Ranking
     22.19
Insiders Shares Cnt. % 3/6/12 mo.
-/100/100 
Income Ranking
 —    -
Market Cap (M)75 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
6.03 
Earnings Date
8th Nov 2019

Today's Price Range

1.501.68

52W Range

1.285.92

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
-3.14%
1 Month
-2.53%
3 Months
-13.97%
6 Months
-26.32%
1 Year
-72.38%
3 Years
-93.43%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
SELB1.560.02001.30
AAPL263.902.16000.83
GOOG1 317.00-3.5400-0.27
MSFT149.80-0.0500-0.03
XOM68.45-0.2000-0.29
WFC53.11-0.1300-0.24
JNJ138.84-0.5400-0.39
FB199.020.31000.16
GE10.83-0.0700-0.64
JPM132.550.21000.16
Earnings HistoryEstimateReportedSurprise %
Q03 2019-0.28-0.267.14
Q02 2019-0.34-0.37-8.82
Q01 2019-0.37-0.3116.22
Q04 2018-0.76-0.6514.47
Q03 2018-0.79-0.7110.13
Q02 2018-0.72-0.84-16.67
Q01 2018--0.71-
Q04 20170.00-0.88-
Earnings Per EndEstimateRevision %Trend
12/2019 QR-0.29-11.54Negative
12/2019 FY-1.23-7.89Negative
3/2020 QR-0.2777.50Positive
12/2020 FY-0.80--
Next Report Date-
Estimated EPS Next Report-0.28
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume582 300
Shares Outstanding (K)48 196
Trades Count941
Dollar Volume922 177
Avg. Volume341 279
Avg. Weekly Volume204 010
Avg. Monthly Volume181 373
Avg. Quarterly Volume160 051
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Selecta Biosciences Inc.

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company is engaged in using synthetic vaccine particle or SVP technology to discover and develop targeted therapies to modulate the immune system effectively and safely treat rare and serious diseases. It provides SVP for immune tolerance and stimulation. The company products in Phase 1 and Phase 2 include SEL-403 for Pancreatic Cancer and Mesothelioma, SEL-212 for Chronic Severe Gout, SEL-302 for Methylmalonic Acidemia (MMA) and SEL-313 for Ornithine Transcarbamylase Deficiency (OTC).

CEO: Carsten Brunn

Teplephone: +1 617 923-1400

Address: 480 Arsenal Way, Watertown 02472, MA, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

33%67%

Bearish Bullish

39%61%

Bearish Bullish

50%50%

News

Stocktwits